225 related articles for article (PubMed ID: 15146554)
1. Increased adenoviral transduction efficacy in human laryngeal carcinoma cells resistant to cisplatin is associated with increased expression of integrin alphavbeta3 and coxsackie adenovirus receptor.
Ambriović-Ristov A; Gabrilovac J; Cimbora-Zovko T; Osmak M
Int J Cancer; 2004 Jul; 110(5):660-7. PubMed ID: 15146554
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB
Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of the coxsackie and adenovirus receptor downregulates αvβ3 and αvβ5 integrin expression and reduces cell adhesion and migration.
Majhen D; Stojanović N; Špeljko T; Brozovic A; De Zan T; Osmak M; Ambriović-Ristov A
Life Sci; 2011 Aug; 89(7-8):241-9. PubMed ID: 21712047
[TBL] [Abstract][Full Text] [Related]
4. CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta.
Brüning A; Runnebaum IB
Gene Ther; 2003 Feb; 10(3):198-205. PubMed ID: 12571626
[TBL] [Abstract][Full Text] [Related]
5. alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species.
Brozovic A; Majhen D; Roje V; Mikac N; Jakopec S; Fritz G; Osmak M; Ambriovic-Ristov A
Mol Pharmacol; 2008 Jul; 74(1):298-306. PubMed ID: 18441044
[TBL] [Abstract][Full Text] [Related]
6. Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells.
Nalbantoglu J; Pari G; Karpati G; Holland PC
Hum Gene Ther; 1999 Apr; 10(6):1009-19. PubMed ID: 10223734
[TBL] [Abstract][Full Text] [Related]
7. Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin.
Bangari DS; Mittal SK
Virology; 2005 Feb; 332(1):157-66. PubMed ID: 15661148
[TBL] [Abstract][Full Text] [Related]
8. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
9. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy.
Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC
J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193
[TBL] [Abstract][Full Text] [Related]
10. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.
Fechner H; Haack A; Wang H; Wang X; Eizema K; Pauschinger M; Schoemaker R; Veghel R; Houtsmuller A; Schultheiss HP; Lamers J; Poller W
Gene Ther; 1999 Sep; 6(9):1520-35. PubMed ID: 10490761
[TBL] [Abstract][Full Text] [Related]
11. Differential role of alpha(v)beta(3) and alpha(v)beta(5) integrins in internalization and transduction efficacies of wild type and RGD4C fiber-modified adenoviruses.
Majhen D; Nemet J; Richardson J; Gabrilovac J; Hajsig M; Osmak M; Eloit M; Ambriović-Ristov A
Virus Res; 2009 Jan; 139(1):64-73. PubMed ID: 19013487
[TBL] [Abstract][Full Text] [Related]
12. Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.
Sachs MD; Rauen KA; Ramamurthy M; Dodson JL; De Marzo AM; Putzi MJ; Schoenberg MP; Rodriguez R
Urology; 2002 Sep; 60(3):531-6. PubMed ID: 12350512
[TBL] [Abstract][Full Text] [Related]
13. Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts.
Fuxe J; Liu L; Malin S; Philipson L; Collins VP; Pettersson RF
Int J Cancer; 2003 Mar; 103(6):723-9. PubMed ID: 12516090
[TBL] [Abstract][Full Text] [Related]
14. Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapy.
Marsee DK; Vadysirisack DD; Morrison CD; Prasad ML; Eng C; Duh QY; Rauen KA; Kloos RT; Jhiang SM
Thyroid; 2005 Sep; 15(9):977-87. PubMed ID: 16187905
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
[TBL] [Abstract][Full Text] [Related]
16. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
Kaner RJ; Worgall S; Leopold PL; Stolze E; Milano E; Hidaka C; Ramalingam R; Hackett NR; Singh R; Bergelson J; Finberg R; Falck-Pedersen E; Crystal RG
Am J Respir Cell Mol Biol; 1999 Mar; 20(3):361-70. PubMed ID: 10030833
[TBL] [Abstract][Full Text] [Related]
17. Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity.
Majhen D; Brozovic A; Buger T; Gabrilovac J; Osmak M; Ambriović-Ristov A
Life Sci; 2010 Oct; 87(15-16):468-74. PubMed ID: 20837033
[TBL] [Abstract][Full Text] [Related]
18. Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor.
Lee EM; Hong SH; Lee YJ; Kang YH; Choi KC; Choi SH; Kim IH; Lim SJ
J Cancer Res Clin Oncol; 2004 Mar; 130(3):169-77. PubMed ID: 14677059
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
20. Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.
Candolfi M; Curtin JF; Xiong WD; Kroeger KM; Liu C; Rentsendorj A; Agadjanian H; Medina-Kauwe L; Palmer D; Ng P; Lowenstein PR; Castro MG
Mol Ther; 2006 Sep; 14(3):371-81. PubMed ID: 16798098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
